United Therapeutics Corporation (NASDAQ:UTHR) Q2 2023 Earnings Call Transcript August 2, 2023
United Therapeutics Corporation misses on earnings expectations. Reported EPS is $2.41 EPS, expectations were $4.41.
Operator: Good morning, and welcome to the United Therapeutics Corporation Second Quarter 2023 Earnings Webcast. My name is Danielle, and I will be your conference operator today. [Operator Instructions] Please note, this call is being recorded. I will now turn the webcast over to...
